美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

NervGen Pharma Corp.

2.20

+0.01000.46%

盤後：2.19-0.0050-0.23%19:30 EDT

成交量：23.84萬

成交額：52.71萬

市值：2.37億

市盈率：-3.84

高：2.25

開：2.18

低：2.18

收：2.19

52周最高：6.30

52周最低：1.58

股本：1.08億

流通股本：9,539.12萬

量比：0.41

換手率：0.25%

股息：- -

股息率：- -

每股收益(TTM):-0.5710

每股收益(LYR):-0.4448

淨資產收益率：-757.48%

總資產收益率：-37.70%

市淨率：19.09

市盈率(LYR):-4.93

資料載入中...

總覽公司新聞資訊公告

NervGen Pharma Corp - Nvg-291在1B/2a期Connect Sci研究中顯示出統計學顯著的步態質量改善

熱門話題-NervGen Pharma因發行股票及認股權證而股價暴跌

NervGen Pharma Corp啓動普通股、認股權證及預融資認股權證承銷公開發行

NervGen Pharma 公司——淨收益將用於推進Nvg-291臨床研究及一般公司用途

NervGen藥業任命基思·文多拉為首席財務官，強化領導團隊實力

BUZZ--美國股票走勢-醫療保險公司、Arista、Savara

NervGen Pharma Corp. 即將完成1B/2a期CONNECT-SCI亞急性四肢癱患者入組並揭盲數據

NervGen Pharma宣佈成功完成二期臨床試驗結束會議，並與FDA就慢性四肢癱瘓治療藥物Nvg-291的三期註冊研究"Restore"達成共識

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/NGEN/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NGEN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NGEN\",,,,,undefined,":{"symbol":"NGEN","market":"US","secType":"STK","nameCN":"NervGen Pharma Corp.","latestPrice":2.195,"timestamp":1789416000000,"preClose":2.185,"halted":0,"volume":238408,"hourTrading":{"tag":"盘后","latestPrice":2.19,"preClose":2.195,"latestTime":"19:30 EDT","volume":534,"amount":1185.255,"timestamp":1789428602063,"change":-0.005,"changeRate":-0.002278,"amplitude":0.002278},"delay":0,"changeRate":0.004576659038901504,"floatShares":95391200,"shares":108000000,"eps":-0.571,"marketStatus":"未開盤","change":0.01,"latestTime":"09-14 16:00:00 EDT","open":2.18,"high":2.25,"low":2.175,"amount":527138.9222319999,"amplitude":0.034325,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.571,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789459200000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":2.185,"preHourTrading":{"tag":"盘前","latestPrice":2.1672,"preClose":2.185,"latestTime":"08:58 EDT","volume":4345,"amount":9344.682006,"timestamp":1789390729944,"change":-0.0178,"changeRate":-0.008146,"amplitude":0.02746},"postHourTrading":{"tag":"盘后","latestPrice":2.19,"preClose":2.195,"latestTime":"19:30 EDT","volume":534,"amount":1185.255,"timestamp":1789428602063,"change":-0.005,"changeRate":-0.002278,"amplitude":0.002278},"volumeRatio":0.414855,"impliedVol":0.0812,"impliedVolPercentile":0.2284},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NGEN\",,,,,undefined,":{"symbol":"NGEN","floatShares":95391200,"roa":"-37.70%","roe":"-757.48%","lyrEps":-0.444846,"volumeRatio":0.414855,"shares":108000000,"dividePrice":0,"high":2.25,"amplitude":0.034325,"preClose":2.185,"low":2.175,"week52Low":1.58,"pbRate":"19.09","week52High":6.3,"institutionHeld":0,"latestPrice":2.195,"eps":-0.571,"divideRate":0,"volume":238408,"delay":0,"ttmEps":-0.571,"open":2.18,"prevYearClose":5.6,"prevWeekClose":2.185,"prevMonthClose":2.21,"prevQuarterClose":2.06,"fiveDayClose":2.33,"twentyDayClose":1.735,"sixtyDayClose":2.19},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NGEN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"NGEN","fiscalQuarterEnding":"2026/06","expectedEps":-0.09,"name":null,"time":"盤前","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"pre","actualEps":-0.37},{"market":"US","date":"2026-05-15","symbol":"NGEN","fiscalQuarterEnding":"2026/03","expectedEps":-0.07,"name":null,"time":"盤後","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"post","actualEps":-0.09},{"date":"2026-03-31","symbol":"NGEN","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774944000000,"name":null,"time":"盤前","dateTimestamp":1774929600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NGEN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NGEN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.125,"buy":0.875,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.875,"analysts":8,"updateTime":1784001600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NGEN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NGEN","date":"2026-09-11","current":-3.844133,"percent":0.946108,"low":-25.148356,"twenty":-17.261061,"median":-9.448244,"eighty":-6.142393,"high":-4.008234,"avg":-11.241259,"sd":5.737561,"marketCap":232248887},"quantilePoints":[{"date":"2026-01-09","current":-25.148356,"twenty":-24.98651,"median":-24.743741,"eighty":-24.500973,"marketCap":463798962.95},{"date":"2026-01-16","current":-23.484013,"twenty":-24.651705,"median":-24.262661,"eighty":-23.546305,"marketCap":432253265.53},{"date":"2026-01-23","current":-22.238177,"twenty":-24.339127,"median":-23.484013,"eighty":-22.456198,"marketCap":412101315.23},{"date":"2026-01-30","current":-17.441707,"twenty":-24.262661,"median":-22.611928,"eighty":-20.307131,"marketCap":329508465.32},{"date":"2026-02-06","current":-16.382746,"twenty":-23.795472,"median":-22.238177,"eighty":-17.908896,"marketCap":306238051.42},{"date":"2026-02-13","current":-17.441707,"twenty":-23.484013,"median":-19.886661,"eighty":-17.285978,"marketCap":327197651.85},{"date":"2026-02-20","current":-18.220355,"twenty":-23.359429,"median":-18.282647,"eighty":-17.285978,"marketCap":340388899.6},{"date":"2026-02-27","current":-17.753166,"twenty":-22.879782,"median":-18.03348,"eighty":-17.410561,"marketCap":331850071.27},{"date":"2026-03-06","current":-17.223686,"twenty":-22.51849,"median":-17.893323,"eighty":-17.27352,"marketCap":321208516.98},{"date":"2026-03-13","current":-16.382746,"twenty":-22.306698,"median":-17.753166,"eighty":-16.993207,"marketCap":307553178.63},{"date":"2026-03-20","current":-16.957011,"twenty":-22.250635,"median":-17.753166,"eighty":-16.888553,"marketCap":316207550},{"date":"2026-03-27","current":-15.785094,"twenty":-21.714925,"median":-17.597437,"eighty":-16.837477,"marketCap":291516280},{"date":"2026-04-02","current":-18.89617,"twenty":-20.942507,"median":-17.535145,"eighty":-16.702393,"marketCap":347270760},{"date":"2026-04-10","current":-10.676925,"twenty":-19.970755,"median":-17.441707,"eighty":-16.494872,"marketCap":340718966},{"date":"2026-04-17","current":-10.464421,"twenty":-19.238183,"median":-17.254832,"eighty":-16.110604,"marketCap":336672423},{"date":"2026-04-24","current":-9.863583,"twenty":-18.837636,"median":-17.005665,"eighty":-12.953446,"marketCap":318058323},{"date":"2026-05-01","current":-9.064424,"twenty":-18.587877,"median":-16.950192,"eighty":-10.62677,"marketCap":293779061},{"date":"2026-05-08","current":-9.632569,"twenty":-18.344939,"median":-16.86331,"eighty":-10.287304,"marketCap":311583853},{"date":"2026-05-15","current":-9.34654,"twenty":-18.295105,"median":-16.834362,"eighty":-10.043494,"marketCap":300253531},{"date":"2026-05-22","current":-9.812417,"twenty":-18.145605,"median":-16.66306,"eighty":-9.800918,"marketCap":297825605},{"date":"2026-05-29","current":-7.287863,"twenty":-18.008563,"median":-16.66306,"eighty":-9.72533,"marketCap":220902522},{"date":"2026-06-05","current":-7.091826,"twenty":-17.902667,"median":-16.382746,"eighty":-9.634252,"marketCap":213468303},{"date":"2026-06-12","current":-6.717699,"twenty":-17.87775,"median":-16.216296,"eighty":-9.423447,"marketCap":200723927},{"date":"2026-06-18","current":-7.855923,"twenty":-17.87775,"median":-15.872071,"eighty":-9.364073,"marketCap":232584867},{"date":"2026-06-26","current":-6.880017,"twenty":-17.753166,"median":-13.39003,"eighty":-9.064424,"marketCap":202847989},{"date":"2026-07-02","current":-7.524736,"twenty":-17.753166,"median":-10.756935,"eighty":-7.674051,"marketCap":221964554},{"date":"2026-07-10","current":-6.687968,"twenty":-17.753166,"median":-10.600843,"eighty":-7.470839,"marketCap":197537832},{"date":"2026-07-17","current":-5.950494,"twenty":-17.703333,"median":-10.394273,"eighty":-7.2635,"marketCap":177359237},{"date":"2026-07-24","current":-5.990968,"twenty":-17.616125,"median":-10.19196,"eighty":-7.15871,"marketCap":177890252},{"date":"2026-07-31","current":-5.701372,"twenty":-17.597437,"median":-10.084942,"eighty":-7.057391,"marketCap":170260212},{"date":"2026-08-07","current":-6.137986,"twenty":-17.522687,"median":-9.917992,"eighty":-6.810664,"marketCap":183029728},{"date":"2026-08-14","current":-6.239509,"twenty":-17.454165,"median":-9.793252,"eighty":-6.730479,"marketCap":187286234},{"date":"2026-08-21","current":-4.207016,"twenty":-17.441707,"median":-9.728074,"eighty":-6.591693,"marketCap":189239834},{"date":"2026-08-28","current":-5.61745,"twenty":-17.34827,"median":-9.659831,"eighty":-6.31363,"marketCap":251065348},{"date":"2026-09-04","current":-5.551208,"twenty":-17.285978,"median":-9.555453,"eighty":-6.177212,"marketCap":249452508},{"date":"2026-09-11","current":-5.179874,"twenty":-17.261061,"median":-9.448244,"eighty":-6.142393,"marketCap":232248887}],"updateTime":1789421714382},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NGEN\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1133039688","title":"NervGen Pharma Corp - Nvg-291在1B/2a期Connect Sci研究中顯示出統計學顯著的步態質量改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1133039688","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133039688?lang=zh_tw&edition=fundamental","pubTime":"2026-05-26 19:16","pubTimestamp":1779794209,"startTime":"0","endTime":"0","summary":"NervGen Pharma Corp. 宣布，其研究性药物Nvg-291在针对多发性硬化症患者的1B/2a期Connect Sci临床研究中，取得了具有统计学显著意义的步态质量改善。研究数据显示，与安慰剂组相比，接受Nvg-291治疗的患者在步态分析的关键指标上表现出显著提升。Nvg-291是一种旨在促进神经修复和功能恢复的新型疗法。公司表示，将继续推进相关临床开发计划，以进一步评估Nvg-291在更广泛神经系统适应症中的安全性与有效性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGEN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637237354","title":"熱門話題-NervGen Pharma因發行股票及認股權證而股價暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2637237354","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637237354?lang=zh_tw&edition=fundamental","pubTime":"2026-05-22 04:29","pubTimestamp":1779395349,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nL4T41Y24J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174712044","title":"NervGen Pharma Corp啓動普通股、認股權證及預融資認股權證承銷公開發行","url":"https://stock-news.laohu8.com/highlight/detail?id=1174712044","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174712044?lang=zh_tw&edition=fundamental","pubTime":"2026-05-22 04:04","pubTimestamp":1779393853,"startTime":"0","endTime":"0","summary":"NervGen Pharma Corp.宣布，公司已启动一项承销公开发行，将发行普通股、认股权证及预融资认股权证。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102911496","title":"NervGen Pharma 公司——淨收益將用於推進Nvg-291臨床研究及一般公司用途","url":"https://stock-news.laohu8.com/highlight/detail?id=1102911496","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102911496?lang=zh_tw&edition=fundamental","pubTime":"2026-05-22 04:04","pubTimestamp":1779393852,"startTime":"0","endTime":"0","summary":"NervGen Pharma 公司宣布，此次融资所得净收益将主要用于推进其核心候选药物Nvg-291的临床研究，并支持公司的一般运营与战略发展。此举旨在加速该疗法的开发进程，为未来的商业化奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGEN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118353180","title":"NervGen藥業任命基思·文多拉為首席財務官，強化領導團隊實力","url":"https://stock-news.laohu8.com/highlight/detail?id=1118353180","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118353180?lang=zh_tw&edition=fundamental","pubTime":"2026-04-27 19:35","pubTimestamp":1777289732,"startTime":"0","endTime":"0","summary":"NervGen药业公司宣布任命基思·文多拉担任首席财务官，这一关键人事变动将显著增强公司的领导团队架构。此次高层调整旨在优化企业财务战略布局，为后续业务拓展提供强有力的支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGEN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625953047","title":"BUZZ--美國股票走勢-醫療保險公司、Arista、Savara","url":"https://stock-news.laohu8.com/highlight/detail?id=2625953047","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625953047?lang=zh_tw&edition=fundamental","pubTime":"2026-04-07 21:08","pubTimestamp":1775567334,"startTime":"0","endTime":"0","summary":".N** 博通公司AVGO.O：BUZZ - 因与谷歌达成开发定制人工智能芯片的长期协议而在盘前上涨  nL4N40Q0HL ** CVS Health Corp CVS.N：** UnitedHealth Group Inc UNH.N：** Elevance Health Inc ELV.N：BUZZ - 美国最终确定将医疗保险优势支付上调 2.48%，医疗保险公司大涨 nL4N40Q0I3 ** Greenwich LifeSciences Inc GLSI.O:BUZZ - 新数据扩大了潜在的乳腺癌药物市场，导致该公司股价上涨。nL4N40Q0PW ** Humana Inc HUM.N:BUZZ - 因医疗保险费率上调而跳涨；富国银行上调评级   nL4N40Q0R7 ** Old Dominion Freight Line Inc ODFL.OODFL.O:BUZZ - 因需求前景强劲，富国银行将其评级上调至 \"等权重\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nL4T40Q0YR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU2860962120.EUR","LU0823411888.USD","LU0320765059.SGD","LU0354030511.USD","CVS","LU0052756011.USD","LU0719512351.SGD","LU0477156953.USD","IE00BQXX3D17.EUR","LU0738911758.USD","LU0320765489.SGD","LU0251132253.USD","IE00B775SV38.USD","SG9999014013.SGD","LU1934455194.USD","BK4585","LU2089984988.USD","LU1069347547.HKD","LU1201861249.SGD","LU1323610961.USD","LU1791710400.SGD","IE00B19Z9Z06.USD","IE00BN0W2W23.USD","LU2279689827.SGD","LU0795875086.SGD","LU0050427557.USD","LU0417517546.SGD","LU0957808578.USD","BK4122","CASY","IE00BLSP4452.SGD","LU1878469433.USD","LU2322448791.USD","IE00BJJMRZ35.SGD","LU2750360641.GBP","SG9999015978.USD","IE00B19Z9505.USD","IE00BDGV0183.EUR","IE00BMPRXN33.USD","LU0128525929.USD","BK4020","LU1868836757.USD","LU1267930730.SGD","IE00B4JS1V06.HKD","IE00BGHQF631.EUR","LU0820561818.USD","IE00BMPRXQ63.HKD","LU1674673691.USD","HUM","LU1778281490.HKD","LU2746668461.USD","SG9999003800.SGD","LU0251131958.USD","IE0002141913.USD","CLYM","LU1935042488.USD","LU2237443382.USD","BKR","LU0127658192.USD","BK4093","IE00BK4W5L77.USD","LU0109392836.USD","LU0795875169.SGD","LU2430703251.USD","SG9999014906.USD","LU0456842615.SGD","LU0742534661.SGD","LU0208291251.USD","IE0009355771.USD","BK4581","LU2250418816.HKD","IE00B0JY6N72.USD","LU0203202063.USD","LU0203345920.USD","UNHG","GLSI","IE00BJT1NW94.SGD","IE00B1XK9C88.USD","LU2087625088.SGD","SGXZ99366536.SGD","LU0912757837.SGD","LU2347655156.SGD","LU0072461881.USD","LU0170899867.USD","LU1119994496.HKD","LU0342679015.USD","IE00BSNM7G36.USD","LU1261432733.SGD","LU1815333072.USD","LU0316494557.USD","LU2041044095.USD","LU0289739699.SGD","LU2458330169.SGD","CF","LU1242518857.USD","LU0107464264.USD","LU0823434583.USD","SG9999014005.SGD","LU2264538146.SGD","IE00BJJMRX11.SGD","LU0784385840.USD","LU1935042215.USD","LU2764262908.HKD","IE0034235188.USD","LU2242649171.HKD","BK4141","IE00BVYPNP33.GBP","LU2271345857.HKD","LU0320765992.SGD","LU0432979614.USD","LU0289960550.SGD","IE00B894F039.SGD","LU2403377893.USD","LU1868837722.USD","LU1242518931.SGD","LU0122379950.USD","LU2417539215.USD","LU2473716301.USD","LU2552382132.HKD","IE00B2B36J28.USD","LU0187121727.USD","LU1852331112.SGD","BK4539","LU0080751232.USD","LU0210528500.USD","LU0058720904.USD","LU1804176565.USD","LU0082616367.USD","IE00B3PB1722.GBP","LU1066051225.USD","LU0106959298.USD","GD","LU0784383803.USD","LU0784384876.USD","LU2237443465.HKD","LU0642271901.SGD","LU1066051498.USD","LU2112291526.USD","BK4504","LU0708995401.HKD","LU1732799900.SGD","LU2360107168.USD","IE00B42XCP33.USD","LU1084165304.USD","LU0274383776.USD","SG9999001077.SGD","SG9999014914.USD","LU1316542783.SGD","LU2750360997.AUD","LU0640476718.USD","LU2602419157.SGD","LU0466842654.USD","LU0553294199.USD","LU0557290698.USD","LU2065171402.SGD","LU2433249047.HKD","LU2023251221.USD","LU2028103732.USD","LU2543165471.USD","LU2360108059.USD","ORGO","LU2063271972.USD","LU0057025933.USD","LU0289739343.SGD","LU2347655073.USD","LU2362541513.USD","SG9999001440.SGD","LU2361044865.SGD","HALO","LU2237957811.SGD","LU2290526834.HKD","LU1670710661.SGD","IE0002270589.USD","BK4612","SG9999015945.SGD","LU0096362180.USD","IE00BFTCPJ56.SGD","LU0472753341.HKD","LU0077335932.USD","LU2362541273.HKD","LU0130517989.USD","LU0980610538.SGD","BK4179","LU1037948897.HKD","LU2361044949.HKD","LU1934455277.USD","IE00BWXC8680.SGD","LU2360107671.USD","LU0433182093.SGD","LU1854104046.USD","BK4516","LU1935042991.SGD","LU0345770308.USD","LU2462157665.USD","AORT","ELV","LU1093756168.USD","BK4213","LU2168564149.EUR","LU2355687059.USD","LU2430703095.HKD","LU2237443549.SGD","LU1868836914.USD","LU0985320562.USD","LU2505996509.AUD","LU0965509101.SGD","LU2324357040.USD","BK4566","LU1720051108.HKD","LU2106854487.HKD","LU0310800379.SGD","LU1003077747.HKD","SG9999002232.USD","IE00B19Z8X17.USD","LU0323591593.USD","LU1974910355.USD","LU0211328371.USD","LU0211331839.USD","IE0008368304.USD","LU0158827781.USD","LU1989772840.SGD","SVRA","LU2133065610.SGD","LU1162221912.USD","LU1861220033.SGD","LU2279701549.SGD","LU1642822529.SGD","LU2054465674.USD","LU0310799852.SGD","LU2125154778.USD","LU0965508806.USD","LU0130102774.USD","LU0158827948.USD","LU2247934214.USD","LU2456880835.USD","UNHW","LU0661504455.SGD","LU1791710582.SGD","ODFL","LU0942090050.USD","LU2211814178.USD","LU0390134368.USD","LU2125909247.SGD","IE00B1BXHZ80.USD","IE00BKPKM429.USD","LU2272731865.HKD","LU0820562030.AUD","LU1074936037.SGD","IE00B3S45H60.SGD","LU2065171311.SGD","LU2552382058.USD","LU0094547139.USD","LU1720051017.SGD","LU0048584097.USD","LU1035775433.USD","LU1934455863.HKD","BK4082","LU0820561909.HKD","SPCE","LU0114720955.EUR","NGEN","LU0029864427.USD","LU0053687314.USD","LU1244550577.SGD","IE00B0169N27.USD","LU1868836591.USD","LU2592432038.USD","LU1127390331.HKD","LU1280957306.USD","LU0431992006.USD","LU1989771016.USD","LU0868486357.SGD","LU2265009873.SGD","LU0124676726.USD","SG9999015986.USD","LU1066051811.HKD","LU1983260115.SGD","LU0353189763.USD","LU2491050071.SGD","BK4532","IE00BJLML261.HKD","LU1989764664.SGD","LU1551013342.USD","LU0965509010.AUD","LU2092937221.SGD","SG9999014880.SGD","LU1037948541.HKD","LU0106261372.USD","IE00BN0W2V16.EUR","LU2237438978.USD","LU0079474960.USD","LU1670627923.USD","LU2125909593.SGD","LU0109394709.USD","LU1670710588.SGD","LU1814569148.SGD","LU1023059063.AUD","IE0031619046.USD","LU1489326972.SGD","IE00BJTD4N35.SGD","LU2463526074.USD","IE00B19Z3B42.SGD","IE00BZ1G4Q59.USD","LU2463028550.USD","BK4113","IE00BKDWB100.SGD","LU2430703178.SGD","LU0689472784.USD","LU2237443895.HKD","IE00BVYPNQ40.USD","LU1951200564.SGD","IE00BK4W5M84.HKD","LU0256863811.USD","AVS","LU1691799644.USD","BK4534","LU2125154935.USD","SG9999001176.SGD","IE00B19Z8W00.USD","IE00BLSP4239.USD","LU2023250330.USD","LU2468319806.SGD","LU1066053197.SGD","CGON","LU0823416689.USD","IE00BN29S564.USD","LU0061475181.USD","LU0097036916.USD","LU1803068979.SGD","MNR","LU0456855351.SGD","LU2097829019.USD","BK4564","LU0011850046.USD","LU1815336760.USD","LU0256331488.USD","SG9999014021.USD","LU0345768740.USD","LU2108987350.USD","LU1992135472.HKD","LU2065170008.USD","IE00B8L5B284.USD","LU0949170426.SGD","IE0005OL40V9.USD","BK4154","LU0175139822.USD","LU1267930490.SGD","SG9999011175.SGD","AVGU","LU2213496289.HKD","BK4550","SG9999017495.SGD","LU0149725797.USD","LU0238689110.USD","LU2931357623.SGD","SGXZ51526630.SGD","LU0976567544.SGD","LU1366192091.USD","LU0965509283.SGD","IE00B775H168.HKD","GB00BDT5M118.USD","LU1059921491.USD","SG9999018865.SGD","BK4216","LU1868837136.USD","SG9999004303.SGD","LU0476273544.USD","LU1951198990.SGD","MELI","IE00BJJMRY28.SGD","LU0496365809.HKD","LU2360032135.SGD","LU0109391861.USD","LU1935043023.USD","LU0211327993.USD","SG9999001176.USD","LU1718418525.SGD","BK4533","AVGW","LU1670711040.USD","LU1699723380.USD","IE000M9KFDE8.USD","BK4598","IE00BJTD4V19.USD","BK4171","LU0868494617.USD","LU0545039389.USD","LU2089284900.SGD","LU1035773651.USD","LU0069063385.USD","LU1861220207.SGD","LU2237957902.USD","LU1057294990.SGD","IE00B66KJ199.SGD","LU0861579265.USD","IE00BFXG1179.USD","LU0006061336.USD","LU0889565833.HKD","LU0210533765.USD","LU0648001328.SGD","LU2298321311.HKD","LU0882574055.USD","PSTV","LU2720916845.USD","LU0314106906.USD","LU0203201768.USD","LU2272731600.USD","BK4187","BK4562","LU0345770993.USD","IE00BQXX3C00.GBP","LU0957791311.USD","LU0310800965.SGD","KMLI","SG9999015952.SGD","LU1868838027.USD","LU2083900584.USD","LU2552382215.SGD","AVGO","LU2023250504.SGD","IE00BGV7N243.SGD","LU1732800096.USD","LU0157215616.USD","LU2168564065.EUR","LU1923622614.USD","IE0009356076.USD","IE00B7SZL793.SGD","IE00BFSS7M15.SGD","LU1366333091.USD","LU1623119135.USD","LU0056508442.USD","LU2471134796.USD","IE00B19Z9P08.USD","LU2211815571.USD","LU2089283258.USD","LU1854103824.USD","LU0784385170.HKD","LU0053666078.USD","LU1145028129.USD","LU2065169927.USD","LU1093756325.SGD","IE0004445239.USD","IE00B8HQ1Z84.USD","LU0211326839.USD","IE00BN8TJ469.HKD","LU1914381329.SGD","LU0964807845.USD","LU0683600562.USD","SGXZ31699556.SGD","LU0787776722.HKD","IE0004445015.USD","LU0868494708.USD","LU0985489474.SGD","LU2272731782.SGD","SG9999001424.SGD","LU2360106780.USD","LU0154245673.USD","IE00BKVL7J92.USD","LU0689626769.HKD","IE00BBT3K403.USD","IE00BZ9MQY76.HKD","LU0266013472.USD","LU0444973449.USD","LU2242650005.HKD","LU0070302665.USD","BK4196","LU1629891620.HKD","LU0234572021.USD","LU1548497426.USD","LU1267930227.SGD","LU1496350502.SGD","LU2746668974.SGD","LU0215105999.USD","LU0234570918.USD","IE00B19Z4B17.USD","LU0048573561.USD","LU0256863902.USD","LU0823434740.USD","SGXZ23171101.USD","LU0289961442.SGD","LU2362540622.SGD","LU2357305700.SGD","UNH","NBIX","BK4515","LU1935043536.SGD","LU1064131342.USD","IE00B7SZLL34.SGD","LU1989772923.USD","LU0345769128.USD","IE0001KFT4U8.USD","LU0143863784.USD","LU1923623000.USD","LU0979878070.USD","LU1232071149.USD","LU2237443622.USD","LU0889565916.HKD","LU1868837300.USD","LU0154236417.USD","IE0009354923.USD","LU1917777945.USD","SG9999014898.SGD","LU2764263203.CNY","LU1992135399.USD","LU1861215975.USD","BK4551","IE00BYV24P56.USD","LU1291159041.SGD","LU2461242641.AUD","LU1674673428.USD","LU0053671581.USD","LU2756315664.SGD","LU2491049909.HKD","IE00BN0W2T93.GBP","IE00B1B80R65.USD","LU1983299246.USD","LU1988902786.USD","LU0143863198.USD","LU2756315318.SGD","LU0348723411.USD","LU2487616109.SGD","SG9999002224.SGD","LU0949170772.SGD","LU0353189680.USD","LU2458330243.SGD","AVL","LU1989764748.USD","LU2237443978.SGD","LU0006306889.USD","LU0061474960.USD","LU0162691827.USD","LU0203347892.USD","CNQ","LU0251142724.SGD","AVGX","IE00B5949003.HKD","BK4512","LU1571399168.USD","LU2322448957.HKD","LU1712237335.SGD","LU1551013425.SGD","SGXZ57979304.SGD","LU1069344957.HKD","LU0345769631.USD","LU0444971666.USD","BK4232","IE0034235303.USD","IE00BQXX3F31.USD","LU0210536198.USD","LU0345768153.USD","SG9999013999.USD","SGXZ81514606.USD","BK4588","LU2764263039.SGD","IE00BGHQDM52.EUR","LU0211326755.USD","LU2089985449.USD","IE00BMPRXR70.SGD","LU0081259029.USD","LU2505996681.GBP","LU0225283273.USD","LU2471134879.HKD","LU0354030438.USD","LU2244417387.USD","LU0532187761.SGD","LU2361045086.USD","LU2491050154.USD","LU1153585028.USD","LU0708994859.HKD","IE00BFSS8Q28.SGD","LU0878866978.SGD","LU0096364046.USD","BK4543","LU1506573853.SGD","LU0210535034.USD","XPOF","LU2236285917.USD","LU2471134952.CNY","IE00B4R5TH58.HKD","BK4554","BK4220","IE00B19Z3581.USD","LU1244550494.USD","BK4022","LU2286300806.USD","IE00BVYPNW00.USD","LU2168563687.JPY","BK4548","LU1244550221.USD","LU0672654240.SGD","LU0726765562.USD","ANET","LU0320765646.SGD","BK4605","LU0154245756.USD","LU1061106388.HKD","AVGG","SG9999018857.SGD","BK4575","LU0943347566.SGD","LU2420271590.USD","LU1861217088.USD","FENC","LU2023250843.SGD","LU2168564222.USD","IE00BVYPNV92.GBP","LU0128525689.USD","LU0068578508.USD","LU2896262040.SGD","LU1670711123.USD","LU2168564495.EUR","LU1267930573.SGD","LU0511384066.AUD","LU2111349929.HKD","LU1670628061.USD","LU0528227936.USD","LU0314104364.USD","BK4139","IE00B7KXQ091.USD","IE00BMCWC346.EUR","LU2471134523.USD","LU0198837287.USD","LU1868837565.USD","LU0786609619.USD","LU1301847155.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1130972687","title":"NervGen Pharma Corp. 即將完成1B/2a期CONNECT-SCI亞急性四肢癱患者入組並揭盲數據","url":"https://stock-news.laohu8.com/highlight/detail?id=1130972687","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130972687?lang=zh_tw&edition=fundamental","pubTime":"2026-04-07 19:31","pubTimestamp":1775561476,"startTime":"0","endTime":"0","summary":"NervGen Pharma Corp. 宣布，其针对亚急性脊髓损伤导致四肢瘫患者的1B/2a期CONNECT-SCI临床试验即将完成患者入组工作。随着这一关键节点的达成，公司下一步将着手进行数据揭盲，以评估其候选药物的有效性与安全性。这一进展标志着该药物在神经修复领域的临床开发迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193065506","title":"NervGen Pharma宣佈成功完成二期臨床試驗結束會議，並與FDA就慢性四肢癱瘓治療藥物Nvg-291的三期註冊研究\"Restore\"達成共識","url":"https://stock-news.laohu8.com/highlight/detail?id=1193065506","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193065506?lang=zh_tw&edition=fundamental","pubTime":"2026-04-07 19:31","pubTimestamp":1775561476,"startTime":"0","endTime":"0","summary":"NervGen Pharma Corp. 近日宣布，已成功完成针对其候选药物Nvg-291用于治疗慢性四肢瘫痪的三期注册研究\"Restore\"的二期临床试验结束会议。此次会议取得了积极成果，公司与美国食品药品监督管理局（FDA）就三期研究的整体开发计划达成了一致。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGEN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}]}}